Psychedelic capitalists justify their decision to go for-profit in the ballroom of America’s most recent for-profit flop.

The new leaders of the psychedelic medicalization industry seem to see themselves as above their own self-proposed rules.

"I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes."

Contributors to the Daily Psychedelic Video platform gather on Zoom to bless the opening of the Psychedelic Video Museum: a collection of ten years’ worth of their shared visions.

Pinchbeck has not publicly engaged in the difficult work of reorganizing his relationship to power, which is a precondition for learning to wield power and authority responsibly. Instead, he has shown that he is predominantly concerned with reestablishing his career and with recentering himself as an authority figure

Eight staff have quit The Third Wave and issued an open statement.

The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.

The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.

Regardless of what conclusions we draw, the topic of psychedelics and identity politics is important at a time when public assumptions about psychedelics are transforming.

The decades-long “War on Drugs” has created a situation in which the use of psychedelics is a social justice issue.